[ad_1]
Although the government recently purchased additional vaccines for Pfizer’s NovaVax and Corona 19, a question mark follows the ‘November herd immunity’. This is due to concerns that discontinuation of AstraZeneca vaccines by the elderly could intensify vaccinations after the second trimester. The government cited people’s participation as a big variable, saying that 70% of people could get vaccinated in November without much trouble.
The government announced the vaccination plan late last month and set the group immunity target in November. The vaccine is expected to be given to 70% of the people who will be vaccinated before November, the period of the influenza epidemic. The reason for not specifying a specific number is due to the existence of the age group under 18 years old. Although it is immediately outside the target group, vaccination can be decided by obtaining evidence that the vaccine is safe and effective even in these age groups. Depending on whether or not they are under the age of 18, the number of target audiences ranges from the early to mid-30 million range.
To date, a total of 79 million vaccines have been secured. However, among them, the amount of supplies expected to be supplied to Korea before April is around 1.5 million people, which is only 1.9% of the insured volume. The remaining 98.1% will be supplied from 2Q. The volume itself was concentrated after the second trimester and the AstraZeneca vaccination of the elderly was delayed. In Israel, which began vaccination on December 19 last year, more than 40% of the country’s citizens received the first vaccination in two months. The population that completed the second vaccination also exceeded 25% of the total.
However, the government believes that the number of subjects will not exceed vaccination capacity in the future. If 250 vaccination centers and 10,000 consigned medical institutions function as planned, 150,000 doses of mRNA vaccine and 1 million doses of virus-carrying vaccine will be vaccinated every day in the second half of the year. If you adjust the vaccination standards for each institution or consider the visiting health center vaccination team, there is a possibility that you will be hit more per day.
However, the authorities cited the degree of participation of the population as a key premise. In a subsequent briefing, the head of the vaccination management team of the Corona 19 Vaccination Response Advocacy Team, Kyung-sil Chung, emphasized that “how many people participate in vaccinations, other than mutant viruses, is the variable to achieve group immunity in November. ” Shin Hye-kyung, head of the Vaccine Supply and Demand Division of the Promotion Team, also announced that it would also materialize NovaVax’s 20 million inoculation plan, which will be supplied from the second quarter. The NovaVax vaccine is made using the synthetic antigen method and can be distributed and stored at 2 to 8 grades as the vector vaccine for viruses such as AstraZeneca and Janssen.
Reporter Song Kyung-mo [email protected]
GoodNews paper ⓒ Kookmin Ilbo (www.kmib.co.kr), unauthorized reproduction, compilation, redistribution prohibited
[ad_2]
